患者特征影响人工智能算法解读阴性筛查数字乳腺断层合成检查的表现
本回顾性队列研究纳入2016年1月1日至2019年12月31日某学术机构的4855例阴性筛查数字乳腺断层合成检查,所有检查均经2年随访无 atypia 或乳腺恶性肿瘤诊断而视为真阴性。使用美国食品药品监督管理局批准的人工智能算法生成病例评分和风险评分,多变量逻辑回归分析显示患者特征影响人工智能算法的病例评分和风险评分。
要点
- 阴性筛查数字乳腺断层合成检查中,黑人患者的假阳性病例评分风险高于白人患者(OR=1.5)。
- 老年患者(71-80岁)的假阳性病例评分风险高于51-60岁患者(OR=1.9)。
- 乳腺极度致密患者的假阳性风险评分风险高于脂肪型乳腺患者(OR=2.8)。
核心结论
- 患者特征影响了美国食品药品监督管理局批准的人工智能算法分析阴性筛查数字乳腺断层合成检查时的病例评分和风险评分。
研究设计与样本
- 回顾性队列研究,纳入某学术机构2016年1月1日至2019年12月31日的阴性筛查数字乳腺断层合成检查,所有检查经2年随访无 atypia 或乳腺恶性肿瘤诊断而视为真阴性;随机选取部分唯一患者以提供广泛的种族和民族分布;最终队列的DBT检查由美国食品药品监督管理局批准的人工智能算法解读,生成病例评分(恶性确定性)和风险评分(1年后续恶性风险);采用多变量逻辑回归分析评分与患者特征的关系。
诊断标准与关键数值
- 阳性检查基于供应商提供的两个评分阈值进行分类;假阳性病例评分在黑人患者中更可能(OR=1.5 [95% CI: 1.2, 1.8]),在亚洲患者中更不可能(OR=0.7 [95% CI: 0.5, 0.9]),相比白人患者;在老年患者(71-80岁)中更可能(OR=1.9 [95% CI: 1.5, 2.5]),在年轻患者(41-50岁)中更不可能(OR=0.6 [95% CI: 0.5, 0.7]),相比51-60岁患者;假阳性风险评分在黑人患者中更可能(OR=1.5 [95% CI: 1.0, 2.0]),在61-70岁患者中更可能(OR=3.5 [95% CI: 2.4, 5.1]),在乳腺极度致密患者中更可能(OR=2.8 [95% CI: 1.3, 5.8]),分别相比白人患者、51-60岁患者和脂肪型乳腺患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Artificial intelligence (AI) is increasingly used to manage radiologists' workloads. The impact of patient characteristics on AI performance has not been well studied. Purpose To understand the impact of patient characteristics (race and ethnicity, age, and breast density) on the performance of an AI algorithm interpreting negative screening digital breast tomosynthesis (DBT) examinations. Materials and Methods This retrospective cohort study identified negative screening DBT examinations from an academic institution from January 1, 2016, to December 31, 2019. All examinations had 2 years of follow-up without a diagnosis of atypia or breast malignancy and were therefore considered true negatives. A subset of unique patients was randomly selected to provide a broad distribution of race and ethnicity. DBT studies in this final cohort were interpreted by a U.S. Food and Drug Administration-approved AI algorithm, which generated case scores (malignancy certainty) and risk scores (1-year subsequent malignancy risk) for each mammogram. Positive examinations were classified based on vendor-provided thresholds for both scores. Multivariable logistic regression was used to understand relationships between the scores and patient characteristics. Results A total of 4855 patients (median age, 54 years [IQR, 46-63 years]) were included: 27% (1316 of 4855) White, 26% (1261 of 4855) Black, 28% (1351 of 4855) Asian, and 19% (927 of 4855) Hispanic patients. False-positive case scores were significantly more likely in Black patients (odds ratio [OR] = 1.5 [95% CI: 1.2, 1.8]) and less likely in Asian patients (OR = 0.7 [95% CI: 0.5, 0.9]) compared with White patients, and more likely in older patients (71-80 years; OR = 1.9 [95% CI: 1.5, 2.5]) and less likely in younger patients (41-50 years; OR = 0.6 [95% CI: 0.5, 0.7]) compared with patients aged 51-60 years. False-positive risk scores were more likely in Black patients (OR = 1.5 [95% CI: 1.0, 2.0]), patients aged 61-70 years (OR = 3.5 [95% CI: 2.4, 5.1]), and patients with extremely dense breasts (OR = 2.8 [95% CI: 1.3, 5.8]) compared with White patients, patients aged 51-60 years, and patients with fatty density breasts, respectively. Conclusion Patient characteristics influenced the case and risk scores of a Food and Drug Administration-approved AI algorithm analyzing negative screening DBT examinations. © RSNA, 2024.
引用
- Nguyen DL, Ren Y, Jones TM, et al. Patient Characteristics Impact Performance of AI Algorithm in Interpreting Negative Screening Digital Breast Tomosynthesis Studies. Radiology. 2024. PMID: 38771177. doi:10.1148/radiol.232286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。